| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.005 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |